University of Minnesota. Driven to Discover.
The vaccine produced a strong immune response and fewer lesions than ACAM2000.
In one key category, under 7% of countries scored in the highest tier.
GAO. Additional efforts would enhance likelihood of effective implementation. GAO-20-273 2020 (published online Feb 19)
GAO. National Biodefense Strategy: Additional efforts would enhance likelihood of effective implementation. GAO-20-273 2020 (published online Feb 19)
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2020 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.